©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2009; 15(48): 6068-6074
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6068
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6068
Table 3 Major water soluble metabolites contributing to differentiation between patients and controls1
| Metabolite | Fold (IBS/healthy control) | P value2 | FDR Q value |
| 2(3H)-furanone | 13.7 | 0.03 | 0.25 |
| Ribitol | 3.6 | NS | 0.25 |
| Heptan | 2.9 | 0.02 | 0.25 |
| L-Mannose | 2.8 | NS | 0.25 |
| Creatinine | 1.7 | 0.04 | 0.25 |
| Dodecane | 1.5 | NS | 0.29 |
| Decanoic acid | 1.3 | NS | 0.52 |
| Dodecanoic acid | -1.5 | NS | 0.25 |
| n-Butylamine | -1.5 | 0.01 | 0.25 |
| D-ribose | -1.5 | NS | 0.25 |
| Glucopyranose | -1.6 | NS | 0.29 |
| Azelaic acid | -1.8 | 0.02 | 0.25 |
| Adipic acid | -2.7 | 0.0008 | 0.05 |
- Citation: Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074
- URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6068.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.6068